| Benjamin Favis, MD | |
|
8914 Us Highway 431, Careplus Family Medical, Albertville, AL 35950-0157 | |
| (256) 279-7200 | |
| (256) 279-5757 |
| Full Name | Benjamin Favis |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 19 Years |
| Location | 8914 Us Highway 431, Albertville, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386781664 | NPI | - | NPPES |
| 1669618310 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD29854 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Decatur Morgan Hospital - Decatur Campus | Decatur, AL | Hospital |
| Athens Limestone Hospital | Athens, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alh Hospitalist | 7517289861 | 11 |
| Anniston Careplus, Llc | 0648557801 | 2 |
| Careplus Family Medical Llc | 9335374255 | 4 |
| Decatur Morgan Hospitalist Group | 6507002094 | 19 |
News Archive
Cleveland Clinic researchers have confirmed for the first time a mechanistic link between the gene HSD17B4 and deadly, treatment-resistant prostate cancer.
Dr. David Mack of Advanced Orthopaedics & Spine Medicine and North Cypress Medical Center are participating in a ten year follow-up trial of the ConforMIS iUni® G2 knee resurfacing device, an FDA cleared implant for patients with osteoarthritic damage in a single compartment of the knee.
Avacor(R )Products LLC (http://www.avacor.com), a leading product line in the hair re-growth industry, has recently teamed up with two charitable organizations, HopeCuts, a division of City of Hope (http://www.cityofhope.org), and Team Continuum (http://www.teamcontinuum.net). Avacor((R)) is teaming up with both charities in an effort to help those fighting cancer as well as to help find new ways to fight this prolific disease.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc. – Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Hydromorphone Hydrochloride Extended-release Tablets, 8 mg, 12 mg, and 16 mg.
› Verified 4 days ago
| Entity Name | Sleep & Pulmonary Care Center, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346406469 PECOS PAC ID: 5799850731 Enrollment ID: O20080826000497 |
News Archive
Cleveland Clinic researchers have confirmed for the first time a mechanistic link between the gene HSD17B4 and deadly, treatment-resistant prostate cancer.
Dr. David Mack of Advanced Orthopaedics & Spine Medicine and North Cypress Medical Center are participating in a ten year follow-up trial of the ConforMIS iUni® G2 knee resurfacing device, an FDA cleared implant for patients with osteoarthritic damage in a single compartment of the knee.
Avacor(R )Products LLC (http://www.avacor.com), a leading product line in the hair re-growth industry, has recently teamed up with two charitable organizations, HopeCuts, a division of City of Hope (http://www.cityofhope.org), and Team Continuum (http://www.teamcontinuum.net). Avacor((R)) is teaming up with both charities in an effort to help those fighting cancer as well as to help find new ways to fight this prolific disease.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc. – Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Hydromorphone Hydrochloride Extended-release Tablets, 8 mg, 12 mg, and 16 mg.
› Verified 4 days ago
| Entity Name | Decatur Morgan Hospitalist Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972843134 PECOS PAC ID: 6507002094 Enrollment ID: O20130430000107 |
News Archive
Cleveland Clinic researchers have confirmed for the first time a mechanistic link between the gene HSD17B4 and deadly, treatment-resistant prostate cancer.
Dr. David Mack of Advanced Orthopaedics & Spine Medicine and North Cypress Medical Center are participating in a ten year follow-up trial of the ConforMIS iUni® G2 knee resurfacing device, an FDA cleared implant for patients with osteoarthritic damage in a single compartment of the knee.
Avacor(R )Products LLC (http://www.avacor.com), a leading product line in the hair re-growth industry, has recently teamed up with two charitable organizations, HopeCuts, a division of City of Hope (http://www.cityofhope.org), and Team Continuum (http://www.teamcontinuum.net). Avacor((R)) is teaming up with both charities in an effort to help those fighting cancer as well as to help find new ways to fight this prolific disease.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc. – Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Hydromorphone Hydrochloride Extended-release Tablets, 8 mg, 12 mg, and 16 mg.
› Verified 4 days ago
| Entity Name | Careplus Family Medical Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639503055 PECOS PAC ID: 9335374255 Enrollment ID: O20131031001169 |
News Archive
Cleveland Clinic researchers have confirmed for the first time a mechanistic link between the gene HSD17B4 and deadly, treatment-resistant prostate cancer.
Dr. David Mack of Advanced Orthopaedics & Spine Medicine and North Cypress Medical Center are participating in a ten year follow-up trial of the ConforMIS iUni® G2 knee resurfacing device, an FDA cleared implant for patients with osteoarthritic damage in a single compartment of the knee.
Avacor(R )Products LLC (http://www.avacor.com), a leading product line in the hair re-growth industry, has recently teamed up with two charitable organizations, HopeCuts, a division of City of Hope (http://www.cityofhope.org), and Team Continuum (http://www.teamcontinuum.net). Avacor((R)) is teaming up with both charities in an effort to help those fighting cancer as well as to help find new ways to fight this prolific disease.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc. – Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Hydromorphone Hydrochloride Extended-release Tablets, 8 mg, 12 mg, and 16 mg.
› Verified 4 days ago
| Entity Name | Hospital Physician Services - Southeast Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760410385 PECOS PAC ID: 5597774554 Enrollment ID: O20140219000913 |
News Archive
Cleveland Clinic researchers have confirmed for the first time a mechanistic link between the gene HSD17B4 and deadly, treatment-resistant prostate cancer.
Dr. David Mack of Advanced Orthopaedics & Spine Medicine and North Cypress Medical Center are participating in a ten year follow-up trial of the ConforMIS iUni® G2 knee resurfacing device, an FDA cleared implant for patients with osteoarthritic damage in a single compartment of the knee.
Avacor(R )Products LLC (http://www.avacor.com), a leading product line in the hair re-growth industry, has recently teamed up with two charitable organizations, HopeCuts, a division of City of Hope (http://www.cityofhope.org), and Team Continuum (http://www.teamcontinuum.net). Avacor((R)) is teaming up with both charities in an effort to help those fighting cancer as well as to help find new ways to fight this prolific disease.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc. – Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Hydromorphone Hydrochloride Extended-release Tablets, 8 mg, 12 mg, and 16 mg.
› Verified 4 days ago
| Entity Name | Alh Hospitalist |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770992398 PECOS PAC ID: 7517289861 Enrollment ID: O20141124001005 |
News Archive
Cleveland Clinic researchers have confirmed for the first time a mechanistic link between the gene HSD17B4 and deadly, treatment-resistant prostate cancer.
Dr. David Mack of Advanced Orthopaedics & Spine Medicine and North Cypress Medical Center are participating in a ten year follow-up trial of the ConforMIS iUni® G2 knee resurfacing device, an FDA cleared implant for patients with osteoarthritic damage in a single compartment of the knee.
Avacor(R )Products LLC (http://www.avacor.com), a leading product line in the hair re-growth industry, has recently teamed up with two charitable organizations, HopeCuts, a division of City of Hope (http://www.cityofhope.org), and Team Continuum (http://www.teamcontinuum.net). Avacor((R)) is teaming up with both charities in an effort to help those fighting cancer as well as to help find new ways to fight this prolific disease.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc. – Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Hydromorphone Hydrochloride Extended-release Tablets, 8 mg, 12 mg, and 16 mg.
› Verified 4 days ago
| Entity Name | Huntsville Careplus, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801284195 PECOS PAC ID: 6103104708 Enrollment ID: O20161102002211 |
News Archive
Cleveland Clinic researchers have confirmed for the first time a mechanistic link between the gene HSD17B4 and deadly, treatment-resistant prostate cancer.
Dr. David Mack of Advanced Orthopaedics & Spine Medicine and North Cypress Medical Center are participating in a ten year follow-up trial of the ConforMIS iUni® G2 knee resurfacing device, an FDA cleared implant for patients with osteoarthritic damage in a single compartment of the knee.
Avacor(R )Products LLC (http://www.avacor.com), a leading product line in the hair re-growth industry, has recently teamed up with two charitable organizations, HopeCuts, a division of City of Hope (http://www.cityofhope.org), and Team Continuum (http://www.teamcontinuum.net). Avacor((R)) is teaming up with both charities in an effort to help those fighting cancer as well as to help find new ways to fight this prolific disease.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc. – Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Hydromorphone Hydrochloride Extended-release Tablets, 8 mg, 12 mg, and 16 mg.
› Verified 4 days ago
| Entity Name | Anniston Careplus, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295275139 PECOS PAC ID: 0648557801 Enrollment ID: O20170426001461 |
News Archive
Cleveland Clinic researchers have confirmed for the first time a mechanistic link between the gene HSD17B4 and deadly, treatment-resistant prostate cancer.
Dr. David Mack of Advanced Orthopaedics & Spine Medicine and North Cypress Medical Center are participating in a ten year follow-up trial of the ConforMIS iUni® G2 knee resurfacing device, an FDA cleared implant for patients with osteoarthritic damage in a single compartment of the knee.
Avacor(R )Products LLC (http://www.avacor.com), a leading product line in the hair re-growth industry, has recently teamed up with two charitable organizations, HopeCuts, a division of City of Hope (http://www.cityofhope.org), and Team Continuum (http://www.teamcontinuum.net). Avacor((R)) is teaming up with both charities in an effort to help those fighting cancer as well as to help find new ways to fight this prolific disease.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc. – Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Hydromorphone Hydrochloride Extended-release Tablets, 8 mg, 12 mg, and 16 mg.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Benjamin Favis, MD 8914 Us Highway 431, Careplus Family Medical, Albertville, AL 35950-0157 Ph: (256) 279-7200 | Benjamin Favis, MD 8914 Us Highway 431, Careplus Family Medical, Albertville, AL 35950-0157 Ph: (256) 279-7200 |
News Archive
Cleveland Clinic researchers have confirmed for the first time a mechanistic link between the gene HSD17B4 and deadly, treatment-resistant prostate cancer.
Dr. David Mack of Advanced Orthopaedics & Spine Medicine and North Cypress Medical Center are participating in a ten year follow-up trial of the ConforMIS iUni® G2 knee resurfacing device, an FDA cleared implant for patients with osteoarthritic damage in a single compartment of the knee.
Avacor(R )Products LLC (http://www.avacor.com), a leading product line in the hair re-growth industry, has recently teamed up with two charitable organizations, HopeCuts, a division of City of Hope (http://www.cityofhope.org), and Team Continuum (http://www.teamcontinuum.net). Avacor((R)) is teaming up with both charities in an effort to help those fighting cancer as well as to help find new ways to fight this prolific disease.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc. – Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Hydromorphone Hydrochloride Extended-release Tablets, 8 mg, 12 mg, and 16 mg.
› Verified 4 days ago
Stephen J Babbino, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 604 Smith Rd, Albertville, AL 35951 Phone: 256-891-1460 Fax: 256-891-2640 | |
Larry R Johnston, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3442 Us Highway 431, Albertville, AL 35950 Phone: 256-593-1234 Fax: 256-593-8553 | |
Dr. Gary Alan Calhoun, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 11491 Us Highway 431, Albertville, AL 35950 Phone: 256-894-6976 | |
Messalina Charisse Jordan, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3520 Us Highway 431 Ste 100, Albertville, AL 35950 Phone: 256-849-0500 Fax: 256-573-1021 | |
Dr. Morgan Lacey Goss, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 431 N Carlisle St, Albertville, AL 35950 Phone: 256-251-2566 Fax: 256-344-8334 | |
Dr. Michael Wayne Peters, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5104 Us Highway 431, Albertville, AL 35950 Phone: 256-878-8180 Fax: 256-891-3693 |